Standard delivery is 1-2 working days
 
Free delivery over £550 (excludes cold chain)

Pharmacy Information

About medfx's Pharmacy

All prescription only medicines purchased on www.medfx.co.uk are fulfilled by the medfx Pharmacy. Med-fx Limited is owned by DD Products and Services Ltd. Med-fx Limited is a registered pharmacy on the GPhC.

The medfx pharmacy began operation in 2008 to support the growing requirement for the supply of Botulinum Toxins, Facial Fillers, Cosmeceuticals and Sundries to the patients of registered Doctors, Dentists and Nurse Prescribers.

Find Your Nearest Pharmacy

Head Office - medfx

Unit 3 Perry Way,
Witham,
Essex,
CM8 3SX

Premises No: 1092324

Superintendent: Ashish Jari GPhC: 2054339
GPhC: 2054339

Tel: 01376 532800

medfx (Ireland)

BF Mulholland,
58 Glenavy Road,
Crumlin,
Northern Ireland,
BT29 4LA

Premises No: PSNI 570

Superintendent: Ashish Jari PSNI 7856

Tel: 02894 452668

medfx (Scotland)

Units 1-3, block 5,
Manor Farm Business Park,
Manor Farm,
Stirling,
Scotland,
FK9 5QD

Premises No: 9011925

Superintendent: Ashish Jari

Tel: 01376 532800

medfx (Harley St)

Dajani Pharmacy,
21 New Cavendish St,
London,
W1G 9TY

Premises No: 1041306

Superintendent: Hani Dajani GPhC no: 2019154

Operated on behalf of Med-fx Limited and DD Group by Dajani Ltd GPhC No 2019154

Tel: 01376 509377

medfx Pharmacy Registration Numbers

Premises GPhC no. 1092324

imagedxbc.png

What is this?

Pharmacy Superintendent: Ashish Jari
Superintendent GPhC no: 2054339

Complaints Procedure

If you have a complaint or are not fully satisfied with your service please email our pharmacy at customerresolutions@medfx.co.uk

Pharmacy Register

All registration numbers and validation of our Pharmacy license can be checked online: 

www.pharmacyregulation.org/registers

medfx GPhc Registered Pharmacy Address

medfx Pharmacy,
DD,
Unit 3,
Perry Way,
Witham,
Essex,
CM8 3SX

DD Business Address

DD Products and Services Ltd,
Unit 3,
Perry Way,
Witham,
Essex,
CM8 3SX

Raising A Complaint?

Please visit: https://www.pharmacyregulation.org/reporting-concerns